GCM
GWPH

Gables Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Gables Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,550
Closed -$987K – 387
2021
Q1 		$987K Sell
4,550
-1,000
-18% -$188K 0.54% 51
2020
Q4 		$641K Buy
5,550
+300
+6% +$33.6K 0.37% 65
2020
Q3 		$511K Sell
5,250
-150
-3% -$17.3K 0.33% 70
2020
Q2 		$663K Sell
5,400
-700
-11% -$79.4K 0.46% 55
2020
Q1 		$537K Buy
6,100
+600
+11% +$63.5K 0.44% 57
2019
Q4 		$573K Buy
5,500
+4,350
+378% +$488K 0.38% 73
2019
Q3 		$132K Hold
1,150
– – 0.09% 143
2019
Q2 		$198K Hold
1,150
– – 0.16% 108
2019
Q1 		$194K Buy
+1,150
New +$171K 0.16% 103

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Gables Capital Management's GWPH Position: Q2 2021 in Review

Gables Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 4,550 shares — an estimated $987K sold.

Gables Capital Management first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $987K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Gables Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Gables Capital Management sold 4,550 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $987K.
  • Gables Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
  • Gables Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $987K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Gables Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.